Holen Sie sich die Stockscreener-App
4.25
3.19%
-0.14
Handel nachbörslich:
4.29
0.04
+0.94%
Schlusskurs vom Vortag:
$4.39
Offen:
$4.46
24-Stunden-Volumen:
13,346
Relative Volume:
0.22
Marktkapitalisierung:
$4.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.82M
KGV:
-0.00615
EPS:
-691.4213
Netto-Cashflow:
$-8.08M
1W Leistung:
-10.15%
1M Leistung:
-16.34%
6M Leistung:
-35.61%
1J Leistung:
-16.91%
1-Tages-Spanne:
$4.24
$4.46
1-Wochen-Bereich:
$4.20
$4.80
52-Wochen-Spanne:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Vergleichen Sie NDRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.25 | 5.12M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
623.91 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.75 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
694.75 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.04 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.95 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
$5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now! - openPR.com
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRAJanuary 2026 Focus - openPR.com
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA – January 2026 Focus - Barchart.com
Why ENDRA Life Sciences Inc. stock attracts high net worth investorsPortfolio Update Summary & Real-Time Volume Triggers - ulpravda.ru
Will ENDRA Life Sciences Inc. stock benefit from automationChart Signals & Weekly Momentum Picks - Улправда
Can ENDRA Life Sciences Inc. stock attract ESG capital inflows2025 Short Interest & Real-Time Market Sentiment Alerts - Улправда
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside - openPR.com
ENDRA Life Sciences Inc.Common Stock (Nasdaq:NDRA) Stock Quote - FinancialContent
Why ENDRA Life Sciences Inc. stock is favored by pension fundsMarket Risk Analysis & High Accuracy Trade Alerts - Улправда
What technical charts say about ENDRA Life Sciences Inc. stock2025 Investor Takeaways & Community Shared Stock Ideas - Улправда
Quarterly Risk: What technical charts say about ENDRA Life Sciences Inc. stockOptions Play & Long-Term Growth Portfolio Plans - Улправда
What hedge fund activity signals for ENDRA Life Sciences Inc. stockJuly 2025 Trends & Consistent Profit Trading Strategies - Улправда
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy - Barchart.com
Endra Life Sciences shareholders approve share increase and board elections - Investing.com
Fat Pitch FinancialsENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy - FinancialContent
Top Premarket Decliners - marketscreener.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
A Look at ENDRA Life Sciences Inc (NDRA) Shares in the Recent Past Indicates Growth - setenews.com
ENDRA Life Sciences (NASDAQ:NDRA) Price Target Lowered to $30.00 at Ascendiant Capital Markets - Defense World
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS Registered - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active - Barchart.com
Aug Rallies: How geopolitical tensions affect ENDRA Life Sciences Inc stockProfit Target & Weekly High Return Stock Forecasts - Bộ Nội Vụ
Ascendiant Capital Maintains ENDRA Life Sciences (NDRA) Buy Recommendation - Nasdaq
ENDRA Life Sciences (NDRA) Receives Adjusted Price Target with B - GuruFocus
Endra Life Sciences announces results from Taeus liver device feasibility study - MSN
ENDRA’s liver fat measurement device shows high accuracy at key thresholds - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
ENDRA Life Sciences (NDRA) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Endra Life Sciences (NDRA) Announces Promising Results from Live - GuruFocus
ENDRA Life Sciences stock falls after liver device study results By Investing.com - Investing.com Canada
Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use - Business Wire
ENDRA (NASDAQ: NDRA) study supports TAEUS Liver as low-cost MRI-PDFF alternative - Stock Titan
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS Registered Liver Imaging Platform - openPR.com
ENDRA Life Sciences Inc. (NDRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Jobs Data: What technical charts say about ENDRA Life Sciences Inc. stock2025 Short Interest & Step-by-Step Swing Trade Plans - BỘ NỘI VỤ
ENDRA Life Sciences Announces Management Changes - TradingView — Track All Markets
ENDRA Life Sciences Inc. Announces Resignation of Michael Thornton as Chief Technology Officer, Effective November 28, 2025 - marketscreener.com
What analysts say about ENDRA Life Sciences Inc stockBlue Chip Stock Analysis & Free Trading Psychology Coaching - earlytimes.in
You might want to take a look at ENDRA Life Sciences Inc (NDRA) now - Setenews
NDRA registers 2.68M-share resale, pivots to HYPE crypto strategy - Stock Titan
Form DEF 14AOther definitive proxy statements - ADVFN
Form 8-KCurrent report - ADVFN
ENDRA Life Sciences (NASDAQ: NDRA) Advances - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology - Barchart.com
ENDRA Life Sciences (NASDAQ:NDRA) Rating Increased to Sell at Wall Street Zen - Defense World
How Market Conditions Affect Cigniti Technologies Limiteds Growth StrategyHigh Beta Stocks & Double Digit Capital Growth - earlytimes.in
How strong is ENDRA Life Sciences Inc. stock revenue growth2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker - BioSpace
ENDRA’s liver fat measurement device shows strong correlation with MRI By Investing.com - Investing.com Nigeria
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):